China has 70% of a material AI needs, IQE’s CEO warns, Bloomberg reports

Cardiff-based chipmaker IQE reported a 40% increase in revenue, while its shares have surged 849% year to date. CEO Jutta Meier said the semiconductor industry faces a supply constraint that cannot be fully resolved, highlighting ongoing capacity and access challenges despite strong demand and investor interest.

Analysis

IQE’s equity sensitivity is now likely dominated by evidence that its capacity can be monetized at attractive gross margins, rather than by another top-line beat. The key transmission channel is AI optical interconnect demand: if hyperscale data-center buildouts require more indium-phosphide and gallium-arsenide photonics, IQE’s constrained epitaxial-wafer capacity can shift pricing power upstream. AIXTRON, as a critical MOCVD equipment supplier, is a cleaner second-order beneficiary if customer capex plans translate into expansion orders; COHR, LITE and MTSI capture the downstream module and connectivity spend but face more competitive pricing pressure.

The immediate risk is that a sharp share-price move has pulled forward several quarters of operational improvement. Revenue growth is not sufficient without confirmation that utilization, yield and mix are lifting gross margin and operating cash flow; compound-semiconductor businesses have historically destroyed value when capacity is added ahead of end-demand. Over the next 1-3 months, watch for disclosed customer concentration, committed wafer volumes, backlog duration and capex requirements. A guidance raise accompanied by flat margins would be a negative signal, implying pass-through economics rather than scarcity rents.

Consensus may be treating supply scarcity as permanently investable, while the relevant question is whether the bottleneck is IQE-specific IP/process qualification or simply temporarily unavailable manufacturing capacity. If it is the latter, Chinese and incumbent Asian capacity additions could compress pricing within 6-18 months, particularly in mature RF applications. Conversely, qualification cycles in high-performance photonics are long; verified design wins in AI/datacom would support a structurally higher multiple because supply cannot be substituted quickly.

Given limited disclosed information on valuation, order commitments and free-cash-flow conversion, this is an alert rather than a fresh directional recommendation after the momentum move. The appropriate setup is to buy only on confirmation that margin and cash conversion follow revenue, or on a material pullback that resets expectations.

Key Decisions for Investors

• Do not chase IQE at current momentum levels; set an entry watch for a 20-30% pullback or for next results showing both gross-margin expansion and positive operating cash flow. Exit the thesis if management raises revenue expectations while margins or cash conversion deteriorate.
• Create a 1-3 month relative-value watch: long AIXTRON / short SOXX only if IQE or other compound-semiconductor producers announce incremental MOCVD capacity orders. This isolates the equipment-order cycle from broad semiconductor-beta risk; invalidate if AI/datacom capex guidance weakens.
• For AI-optics exposure, favor a basket of COHR, LITE and MTSI over a concentrated IQE position until customer contracts and capacity economics are independently disclosed. Reassess after earnings for order backlog, inventory days and datacom growth versus telecom demand.
• Monitor UK export-control, gallium/indium sourcing and customer-qualification disclosures over the next 6-18 months. Any evidence of alternative qualified epi supply or elevated working-capital needs would warrant avoiding IQE despite continued headline revenue growth.